Cutting fat absorption to halt weight regain

Practitioner

Volumn 242, Issue 1593, 1998, Pages 860-865

  Lean, Michael ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; CYCLOBUTANE DERIVATIVE; LACTONE; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

DIET THERAPY; DRUG EFFECT; GENERAL PRACTICE; HUMAN; INTESTINE ABSORPTION; LOW FAT DIET; OBESITY; PHYSIOLOGY; REVIEW; WEIGHT GAIN;

ANTI-OBESITY AGENTS; CYCLOBUTANES; DIET, FAT-RESTRICTED; FAMILY PRACTICE; HUMANS; INTESTINAL ABSORPTION; LACTONES; OBESITY; WEIGHT GAIN;

EID: 0032233909     PISSN: 00326518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Sjostrum L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschar HPF, Krempf M. European Multicentre Orlistat Study Group. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 1998;352:167-172
2. Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes 1992;6:397-415
3. Pearson GC, De Looy AE, Webster J. Analysis of the dietetic treatment of obesity. J Human Nutrition and Dietetics 1991;2:371-377
4. Perri MG, Nezu AM, Viegner BJ. Improving the long-term management of obesity. Willey Bioscience, New York 1992
5. Lean MEJ. Sibutramine - a review of clinical efficacy. Int J Obes 1997;21:S30-S36